tiprankstipranks
National Healthcare Corp. (NHC)
XASE:NHC

National Healthcare (NHC) AI Stock Analysis

135 Followers

Top Page

NHC

National Healthcare

(NYSE MKT:NHC)

Select Model
Select Model
Select Model
Outperform 78 (OpenAI - 5.2)
Rating:78Outperform
Price Target:
$183.00
▲(33.40% Upside)
Action:ReiteratedDate:02/27/26
The score is driven primarily by strong financial performance (improved profitability, solid cash generation, and very low leverage) and constructive technical momentum (price above key moving averages with positive MACD). Offsetting these strengths are a relatively higher P/E and a modest dividend yield, plus a near-term fundamental watch item of negative 2025 revenue growth.
Positive Factors
Improving cash generation
Sustained, materially stronger cash generation (OCF and FCF) improves the company’s ability to fund operations, cover capital needs, and sustain shareholder returns without relying on external financing. This structural cash conversion supports resilience across reimbursement cycles and strategic flexibility.
Negative Factors
Recent revenue decline
A return to top-line contraction signals persistent demand, reimbursement, or occupancy headwinds. Even modest revenue declines can pressure margins in labor-intensive care operations and limit the runway for margin recovery absent sustained census or rate improvements.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving cash generation
Sustained, materially stronger cash generation (OCF and FCF) improves the company’s ability to fund operations, cover capital needs, and sustain shareholder returns without relying on external financing. This structural cash conversion supports resilience across reimbursement cycles and strategic flexibility.
Read all positive factors

National Healthcare (NHC) vs. SPDR S&P 500 ETF (SPY)

National Healthcare Business Overview & Revenue Model

Company Description
National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. Its skilled nursing...
How the Company Makes Money
NHC generates revenue primarily through the provision of healthcare services, which are funded by government programs such as Medicare and Medicaid, as well as private pay sources. The company earns money through daily service fees charged to pati...

National Healthcare Financial Statement Overview

Summary
Strong overall fundamentals: profitability improved materially (net margin ~8.2% in 2025) and operating/free cash flow strengthened (FCF $148.6M in 2025). Balance sheet is conservatively levered (debt-to-equity 0.08 in 2025). Key risks are the return to negative revenue growth in 2025 (-2.1%) and historical earnings/cash-flow volatility (notably 2022).
Income Statement
72
Positive
Balance Sheet
85
Very Positive
Cash Flow
78
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.51B1.30B1.14B1.07B1.01B
Gross Profit1.02B487.01M429.20M388.11M344.88M
EBITDA213.72M182.53M131.10M68.28M191.56M
Net Income120.02M101.93M66.80M22.45M138.59M
Balance Sheet
Total Assets1.53B1.52B1.31B1.28B1.40B
Cash, Cash Equivalents and Short-Term Investments309.18M216.19M223.62M182.59M256.02M
Total Debt87.07M214.77M93.39M125.94M166.66M
Total Liabilities451.90M541.27M400.32M397.94M494.94M
Stockholders Equity1.07B980.16M908.75M874.28M903.00M
Cash Flow
Free Cash Flow148.63M79.70M83.31M-21.46M23.00M
Operating Cash Flow185.08M107.30M111.22M8.74M62.39M
Investing Cash Flow-33.86M-236.69M-17.57M-5.98M-65.89M
Financing Cash Flow-135.96M100.34M-42.55M-47.64M-35.26M

National Healthcare Technical Analysis

Technical Analysis Sentiment
Positive
Last Price137.18
Price Trends
50DMA
161.94
Positive
100DMA
148.86
Positive
200DMA
130.25
Positive
Market Momentum
MACD
2.61
Negative
RSI
49.92
Neutral
STOCH
57.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NHC, the sentiment is Positive. The current price of 137.18 is below the 20-day moving average (MA) of 163.23, below the 50-day MA of 161.94, and above the 200-day MA of 130.25, indicating a bullish trend. The MACD of 2.61 indicates Negative momentum. The RSI at 49.92 is Neutral, neither overbought nor oversold. The STOCH value of 57.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NHC.

National Healthcare Risk Analysis

National Healthcare disclosed 32 risk factors in its most recent earnings report. National Healthcare reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

National Healthcare Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$2.64B17.6711.57%1.80%23.74%-18.99%
75
Outperform
$1.77B20.669.24%18.77%6.88%
62
Neutral
$2.03B12.545.57%1.69%-22.96%-59.35%
55
Neutral
$2.44B-1.17-39.42%4.58%-61.50%
53
Neutral
$3.23B-9.62-523.78%3.93%-42.22%
53
Neutral
$1.40B7.31953.09%15.48%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NHC
National Healthcare
163.50
72.57
79.80%
ACHC
Acadia Healthcare
26.56
1.83
7.40%
ADUS
Addus Homecare
93.23
-6.01
-6.06%
BKD
Brookdale Senior Living
13.92
7.71
124.15%
SEM
Select Medical
16.38
0.37
2.33%
AVAH
Aveanna Healthcare Holdings
6.63
2.09
46.04%

National Healthcare Corporate Events

Business Operations and StrategyExecutive/Board Changes
National Healthcare Expands Board With Two New Directors
Positive
Feb 17, 2026
National HealthCare Corporation announced on February 17, 2026, that its Board of Directors unanimously expanded from seven to nine members effective February 12, 2026, appointing geriatrician and former AHCA/NCAL executive Dr. David Gifford and l...
Dividends
National HealthCare Declares Quarterly Cash Dividend to Shareholders
Positive
Feb 13, 2026
On February 13, 2026, National HealthCare Corporation announced a quarterly cash dividend of $0.64 per common share, reinforcing its pattern of returning capital to shareholders. The dividend will be paid on April 30, 2026, to shareholders of reco...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 27, 2026